Tuesday, March 18, 2025 | 01:40 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Natco Pharma's drug formulations facility in Telangana receives EIR from USFDA

Image

Capital Market
Natco Pharma announced successful closure of inspection with the receipt of Establishment Inspection Report (EIR) from the U.S. Food and Drug Administration (FDA) for the inspection conducted at its drug formulations facility in Kothur Village, Telangana, India, during the period 30 May - 05 June 2019.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Aug 05 2019 | 2:22 PM IST

Explore News